Light Mode
$26.50 ↓ -0.49 (-1.82%) Trading Down from the previous close of $26.99
-7.19 (-21.04%) / 6M
Momentum, market sentiment, and recent alerts
STOK reads neutral: price sits above one of the two key moving averages, the 12-month move is +6.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.